TY  - GEN
AU  - Bautista, Francisco
AU  - Gallego, Soledad
AU  - Canete, Adela
AU  - Mora, Jaume
AU  - Diaz de Heredia, Cristina
AU  - Cruz, Ofelia
AU  - Maria Fernandez, Jose
AU  - Rives, Susana
AU  - Berlanga, Pablo
AU  - Hladun, Raquel
AU  - Juan Ribelles, Antonio
AU  - Madero, Luis
AU  - Ramirez, Manuel
AU  - Fernandez Delgado, Rafael
AU  - Perez-Martinez, Antonio
AU  - Mata, Cristina
AU  - Llort, Anna
AU  - Martin Broto, Javier
AU  - Elena Cela, Maria
AU  - Ramirez, Gema
AU  - Sabado, Constantino
AU  - Acha, Tomas
AU  - Astigarraga, Itziar
AU  - Sastre, Ana
AU  - Munoz, Ascension
AU  - Guibelalde del Castillo, Mercedes
AU  - Sociedad Espanola Hematologia
AU  - New Drug Dev Grp Pediat Oncology
PY  - 2017
DO  - 10.1016/j.anpedi.2016.07.007
SN  - 1695-4033
UR  - http://hdl.handle.net/20.500.12105/20476
AB  - Introduction: Cancer is the leading cause of death between the first year of life and adolescence, and some types of diseases are still a major challenge in terms of cure. There is, therefore, a major need for new drugs. Recent findings in cancer...
LA  - spa
PB  - Elsevier
KW  - Paediatric haematology and oncology
KW  - Early phase clinical trials
KW  - Drug development
KW  - Personalised medicine
KW  - Child
KW  - Time Factors
KW  - Clinical Trials as Topic
KW  - Spain
KW  - Humans
KW  - Neoplasms
TI  - Early clinical trials in paediatric oncology in Spain: a nationwide perspective
TY  - research article
ER  -